ResearcherJikei University School of MedicineActive in the last 2 years
Toshifumi Ohkusa
Matched on ORCID iD 0000-0002-3029-4201; OpenAlex author ID A5074025359. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide… Co-author DOI 10.1136/jitc-2024-011426↗
- Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable … Co-author DOI 10.1136/jitc-2024-009765↗
- Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-021-08911-4↗
- Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. Co-author DOI 10.1159/000500359↗
- Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ol.2017.6071↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zensho Ito · 5 shared papers, 2017–2025 · strength 0.63
- Paper Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a mult… DOI 10.1136/jitc-2024-011426↗
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-021-08911-4↗
- Shigeo Koido · 5 shared papers, 2017–2025 · strength 0.63
- Paper Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a mult… DOI 10.1136/jitc-2024-011426↗
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-021-08911-4↗
- Masayuki Saruta · 4 shared papers, 2019–2025 · strength 0.57
- Paper Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a mult… DOI 10.1136/jitc-2024-011426↗
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-021-08911-4↗
- Haruo Sugiyama · 4 shared papers, 2019–2025 · strength 0.57
- Paper Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a mult… DOI 10.1136/jitc-2024-011426↗
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-021-08911-4↗
- Shigetaka Shimodaira · 3 shared papers, 2019–2025 · strength 0.46
- Paper Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a mult… DOI 10.1136/jitc-2024-011426↗
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. DOI 10.1159/000500359↗
- Masamori Shimabuku · 2 shared papers, 2024–2025 · strength 0.38
- Paper Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a mult… DOI 10.1136/jitc-2024-011426↗
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Shin Kan · 3 shared papers, 2019–2024 · strength 0.36
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-021-08911-4↗
- Paper Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. DOI 10.1159/000500359↗
- Shintaro Tsukinaga · 1 shared paper, 2024 · strength 0.18
- Shuichi Fujioka · 2 shared papers, 2017–2021 · strength 0.17
- Mikio Kajihara · 2 shared papers, 2017–2019 · strength 0.14
- Sachie Kiryu · 1 shared paper, 2021 · strength 0.11
- Sayumi Yoshida · 1 shared paper, 2019 · strength 0.08
- Masato Okamoto · 1 shared paper, 2019 · strength 0.08
- Tomoya Kanai · 1 shared paper, 2017 · strength 0.06
- Kazuki Takakura · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.